Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USCR
3626
DELISTED
U S Concrete, Inc.
USCR
| $1.01M | ﹤0.01% |
24,212
+7,578
| +46% | +$347K |
|
|
HSKA
3627
DELISTED
Heska Corp
HSKA
| $1.01M | ﹤0.01% |
10,513
+1,227
| +13% | +$106K |
|
|
DO
3628
DELISTED
Diamond Offshore Drilling
DO
| $1.01M | ﹤0.01% |
140,267
-47,728
| -25% | -$277K |
|
3629
Smith & Wesson
SWBI
$651M
| $1.01M | ﹤0.01% |
141,326
-126,123
| -47% | -$769K |
|
3630
REX American Resources
REX
$1.43B
| $1.01M | ﹤0.01% |
73,698
+15,762
| +27% | +$218K |
|
|
SP
3631
DELISTED
SP Plus Corporation
SP
| $1M | ﹤0.01% |
23,660
+9,410
| +66% | +$396K |
|
3632
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $1M | ﹤0.01% |
9,100
-43,700
| -83% | -$4.87M |
|
3633
CALL
Sonos
SONO
$1.83B
| $1M | ﹤0.01% |
64,100
+62,100
| +3,105% | +$865K |
|
3634
CALL
ProShares Ultra S&P500
SSO
$8.26B
| $996K | ﹤0.01% |
52,800
+10,400
| +25% | +$179K |
|
3635
WisdomTree Japan Hedged Equity Fund
DXJ
$7.35B
| $995K | ﹤0.01% |
18,489
+15,595
| +539% | +$832K |
|
3636
PUT
United Therapeutics
UTHR
$22.6B
| $995K | ﹤0.01% |
11,300
+9,600
| +565% | +$845K |
|
|
DCOM
3637
DELISTED
Dime Community Bancshares
DCOM
| $993K | ﹤0.01% |
47,527
+16,322
| +52% | +$335K |
|
3638
CALL
Tapestry
TPR
$32.7B
| $990K | ﹤0.01% |
36,700
-29,500
| -45% | -$769K |
|
3639
Adtran
ADTN
$611M
| $989K | ﹤0.01% |
100,037
+48,216
| +93% | +$459K |
|
3640
Stoneridge
SRI
$205M
| $987K | ﹤0.01% |
33,627
-2,899
| -8% | -$89.2K |
|
|
HZNP
3641
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $987K | ﹤0.01% |
27,259
-143,389
| -84% | -$4.4M |
|
|
WMC
3642
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $986K | ﹤0.01% |
9,551
+1,951
| +26% | +$198K |
|
3643
CALL
Huntington Bancshares
HBAN
$35.1B
| $985K | ﹤0.01% |
65,300
-25,100
| -28% | -$368K |
|
3644
Manitowoc
MTW
$510M
| $985K | ﹤0.01% |
56,265
+19,379
| +53% | +$283K |
|
3645
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $982K | ﹤0.01% |
16,936
+4,700
| +38% | +$272K |
|
3646
OraSure Technologies
OSUR
$275M
| $980K | ﹤0.01% |
122,085
+30,669
| +34% | +$248K |
|
|
GPOR
3647
DELISTED
Gulfport Energy Corp.
GPOR
| $980K | ﹤0.01% |
322,496
-170,528
| -35% | -$484K |
|
3648
PUT
Aflac
AFL
$64.5B
| $979K | ﹤0.01% |
18,500
-63,900
| -78% | -$3.39M |
|
|
QUOT
3649
DELISTED
Quotient Technology Inc
QUOT
| $978K | ﹤0.01% |
99,096
+13,289
| +15% | +$127K |
|
3650
DXP Enterprises
DXPE
$3.07B
| $977K | ﹤0.01% |
24,551
+7,561
| +45% | +$282K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.